C. Rabenstein

441 total citations
7 papers, 350 citations indexed

About

C. Rabenstein is a scholar working on Oncology, Cancer Research and Psychiatry and Mental health. According to data from OpenAlex, C. Rabenstein has authored 7 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 1 paper in Psychiatry and Mental health. Recurrent topics in C. Rabenstein's work include Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). C. Rabenstein is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). C. Rabenstein collaborates with scholars based in Germany and United States. C. Rabenstein's co-authors include Katharina Pachmann, Oumar Camara, Cornelia Jörke, Mieczysław Gajda, Ingo B. Runnebaum, Torsten Kroll, Andreas Kavallaris, Ulrich Pachmann, K. Höffken and A. Altendorf-Hofmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

C. Rabenstein

7 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Rabenstein Germany	6	297	210	96	61	48	7	350
Maria Ntoulia Greece	4	295 1.0×	235 1.1×	96 1.0×	45 0.7×	85 1.8×	5	335
Rachel Payne United Kingdom	7	267 0.9×	292 1.4×	107 1.1×	30 0.5×	110 2.3×	8	387
Sjoerd T. Ligthart Netherlands	7	315 1.1×	238 1.1×	104 1.1×	129 2.1×	71 1.5×	9	414
Veit Zieglschmid Germany	5	247 0.8×	143 0.7×	76 0.8×	142 2.3×	71 1.5×	6	357
Silvia Bessi Italy	9	452 1.5×	354 1.7×	142 1.5×	75 1.2×	106 2.2×	14	566
Nicolas Kiavué France	10	257 0.9×	179 0.9×	110 1.1×	37 0.6×	110 2.3×	13	363
Ahmet Imrali United Kingdom	4	216 0.7×	147 0.7×	41 0.4×	90 1.5×	78 1.6×	9	288
Aian Neil Alilin United States	4	137 0.5×	95 0.5×	109 1.1×	47 0.8×	141 2.9×	8	293
A. Stopeck United States	9	242 0.8×	90 0.4×	80 0.8×	26 0.4×	68 1.4×	20	295
Joanne Lundy Australia	10	274 0.9×	65 0.3×	49 0.5×	29 0.5×	110 2.3×	24	377

Countries citing papers authored by C. Rabenstein

Since Specialization

Citations

This map shows the geographic impact of C. Rabenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rabenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rabenstein more than expected).

Fields of papers citing papers by C. Rabenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rabenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rabenstein. The network helps show where C. Rabenstein may publish in the future.

Co-authorship network of co-authors of C. Rabenstein

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rabenstein. A scholar is included among the top collaborators of C. Rabenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rabenstein. C. Rabenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Rabenstein, C., Martina Stauch, Matthias Rengsberger, et al.. (2013). Chemosensitivity Testing of Circulating Epithelial Tumor Cells (CETC) in <i>Vitro</i>: Correlation to in <i>Vivo</i> Sensitivity and Clinical Outcome. Journal of Cancer Therapy. 4(2). 597–605. 6 indexed citations

2.

Rabenstein, C., et al.. (2012). Epithelial Cell Dissemination and Readhesion: Analysis of Factors Contributing to Metastasis Formation in Breast Cancer. SHILAP Revista de lepidopterología. 2012. 1–8. 17 indexed citations

3.

Pachmann, Katharina, Oumar Camara, C. Rabenstein, et al.. (2010). Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy. Journal of Cancer Research and Clinical Oncology. 137(5). 821–828. 19 indexed citations

4.

Camara, Oumar, Cornelia Jörke, C. Rabenstein, et al.. (2008). Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment. Journal of Cancer Research and Clinical Oncology. 135(4). 643–647. 10 indexed citations

5.

Pachmann, Katharina, et al.. (2008). The impact of systemic chemotherapy on circulating epithelial tumor cells (CETC) in breast cancer. Journal of Clinical Oncology. 26(15_suppl). 11001–11001. 2 indexed citations

6.

Pachmann, Katharina, Oumar Camara, Andreas Kavallaris, et al.. (2008). Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. Journal of Clinical Oncology. 26(8). 1208–1215. 221 indexed citations

7.

Camara, Oumar, Matthias Rengsberger, André Koch, et al.. (2007). The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Annals of Oncology. 18(9). 1484–1492. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact